Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist and Letrozole Pretreatment in Adenomyosis FET
NCT07065539Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2025
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of letrozole in adenomyosis (4 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Live birth rate. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT07065539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07065539.